Literature DB >> 12192243

Update on complement in the pathogenesis of systemic lupus erythematosus.

Hector Molina1.   

Abstract

Complement is involved in inflammation and in the optimization of adaptive responses. Abnormalities in the complement system have been associated with autoimmunity, especially systemic lupus erythematosus. A paradoxic relation exits between complement and lupus. Complement-mediated tissue damage is accepted as a mechanism in disease pathophysiology. Conversely, complement exerts a protective effect in disease development. The theoretic framework explaining this protective influence involves the adequate disposal of apoptotic material by classic pathway components. Inadequate clearance of apoptotic material may evoke a proinflammatory autoimmune response. This conceptual model is substantiated by studies indicating that complement receptor genes are within major susceptibility loci of systemic lupus erythematosus, that functional and structural abnormalities in these receptors are found in lupus mouse models, and that genetic polymorphism of lectin pathway genes correlates with increased risk of disease development. Finally, new diagnostic and therapeutic modalities based on complement regulation have been described in the past year.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192243     DOI: 10.1097/00002281-200209000-00002

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  5 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 2.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

3.  Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.

Authors:  Yuqing Song; Yuelun Zhang; Zhuo Li; Jing Liu; Juan Xiao; Hongmei Song
Journal:  Ann Hematol       Date:  2022-05-09       Impact factor: 3.673

4.  Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort.

Authors:  Beatriz Tejera Segura; Iñigo Rua-Figueroa; Jose Maria Pego-Reigosa; Victor Del Campo; Chris Wincup; David Isenberg; Anisur Rahman
Journal:  BMJ Open       Date:  2019-06-14       Impact factor: 2.692

5.  Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Authors:  Warren Raymond; Gro Eilertsen; Johannes Nossent
Journal:  J Immunol Res       Date:  2018-12-30       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.